Individual participant data meta-analysis of prognostic factor studies: state of the art?
Open Access
- 24 April 2012
- journal article
- research article
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 12 (1) , 56
- https://doi.org/10.1186/1471-2288-12-56
Abstract
Background: Prognostic factors are associated with the risk of a subsequent outcome in people with a given disease or health condition. Meta-analysis using individual participant data (IPD), where the raw data are synthesised from multiple studies, has been championed as the gold-standard for synthesising prognostic factor studies. We assessed the feasibility and conduct of this approach. Methods: A systematic review to identify published IPD meta-analyses of prognostic factors studies, followed by detailed assessment of a random sample of 20 articles published from 2006. Six of these 20 articles were from the IMPACT (International Mission for Prognosis and Analysis of Clinical Trials in traumatic brain injury) collaboration, for which additional information was also used from simultaneously published companion papers. Results: Forty-eight published IPD meta-analyses of prognostic factors were identified up to March 2009. Only three were published before 2000 but thereafter a median of four articles exist per year, with traumatic brain injury the most active research field. Availability of IPD offered many advantages, such as checking modelling assumptions; analysing variables on their continuous scale with the possibility of assessing for non-linear relationships; and obtaining results adjusted for other variables. However, researchers also faced many challenges, such as large cost and time required to obtain and clean IPD; unavailable IPD for some studies; different sets of prognostic factors in each study; and variability in study methods of measurement. The IMPACT initiative is a leading example, and had generally strong design, methodological and statistical standards. Elsewhere, standards are not always as high and improvements in the conduct of IPD meta-analyses of prognostic factor studies are often needed; in particular, continuous variables are often categorised without reason; publication bias and availability bias are rarely examined; and important methodological details and summary results are often inadequately reported. Conclusions: IPD meta-analyses of prognostic factors are achievable and offer many advantages, as displayed most expertly by the IMPACT initiative. However such projects face numerous logistical and methodological obstacles, and their conduct and reporting can often be substantially improved.Keywords
This publication has 69 references indexed in Scilit:
- Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studiesInternational Journal of Epidemiology, 2010
- Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyondBritish Journal of Cancer, 2009
- Individual patient data meta-analysis of diagnostic and prognostic studies in obstetrics, gynaecology and reproductive medicineBMC Medical Research Methodology, 2009
- Predicting Outcome after Traumatic Brain Injury: Development and International Validation of Prognostic Scores Based on Admission CharacteristicsPLoS Medicine, 2008
- A Re-Evaluation of Random-Effects Meta-AnalysisJournal of the Royal Statistical Society Series A: Statistics in Society, 2008
- Prognosis and Clinical Trial Design in Traumatic Brain Injury: The IMPACT StudyJournal of Neurotrauma, 2007
- Prognostic and Predictive Factors in Early-Stage Breast CancerThe Oncologist, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the futureBritish Journal of Cancer, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986